| Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA–B carcinoma of the cervix? A Covens, P Shaw, J Murphy, D DePetrillo, G Lickrish, S Laframboise, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 361 | 1999 |
| A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone E Rakovitch, S Nofech-Mozes, W Hanna, FL Baehner, R Saskin, ... Breast cancer research and treatment 152, 389-398, 2015 | 258 | 2015 |
| EMT in breast carcinoma—a review J Felipe Lima, S Nofech-Mozes, J Bayani, JMS Bartlett Journal of clinical medicine 5 (7), 65, 2016 | 243 | 2016 |
| Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case–control study ME Beiner, J Hauspy, B Rosen, J Murphy, S Laframboise, ... Gynecologic oncology 110 (2), 168-171, 2008 | 191 | 2008 |
| A cluster-then-label semi-supervised learning approach for pathology image classification M Peikari, S Salama, S Nofech-Mozes, AL Martel Scientific reports 8 (1), 1-13, 2018 | 173 | 2018 |
| Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? L Gortzak-Uzan, W Jimenez, S Nofech-Mozes, N Ismiil, MA Khalifa, ... Gynecologic oncology 116 (1), 28-32, 2010 | 172 | 2010 |
| Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers S Nofech-Mozes, M Trudeau, HK Kahn, R Dent, E Rawlinson, P Sun, ... Breast cancer research and treatment 118, 131-137, 2009 | 158 | 2009 |
| HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, ... British journal of cancer 106 (6), 1160-1165, 2012 | 154 | 2012 |
| Identification of a low-risk luminal A breast cancer cohort that may not benefit from breast radiotherapy FF Liu, W Shi, SJ Done, N Miller, M Pintilie, D Voduc, TO Nielsen, ... J Clin Oncol 33 (18), 2035-2040, 2015 | 151 | 2015 |
| Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast PL Fitzgibbons, DA Dillon, R Alsabeh, MA Berman, DF Hayes, DG Hicks, ... Archives of Pathology and Laboratory Medicine 138 (5), 595-601, 2014 | 150 | 2014 |
| Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration SCY Leung, TO Nielsen, L Zabaglo, I Arun, SS Badve, AL Bane, J Bartlett, ... NPJ breast Cancer 2 (1), 1-9, 2016 | 143 | 2016 |
| Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer L Helpman, R Kupets, A Covens, RS Saad, MA Khalifa, N Ismiil, Z Ghorab, ... British journal of cancer 110 (3), 609-615, 2014 | 134 | 2014 |
| Immunophenotyping of serous carcinoma of the female genital tract S Nofech-Mozes, MA Khalifa, N Ismiil, RS Saad, WM Hanna, A Covens, ... Modern pathology 21 (9), 1147-1155, 2008 | 117 | 2008 |
| Prognostic and predictive molecular markers in DCIS: a review S Nofech-Mozes, J Spayne, E Rakovitch, W Hanna Advances in anatomic pathology 12 (5), 256-264, 2005 | 105 | 2005 |
| Intratumoral Heterogeneity of HER2/neu in Breast Cancer—A Rare Event W Hanna, S Nofech‐Mozes, HJ Kahn The breast journal 13 (2), 122-129, 2007 | 102 | 2007 |
| Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ E Rakovitch, S Nofech-Mozes, W Hanna, R Sutradhar, FL Baehner, ... JNCI: Journal of the National Cancer Institute 109 (4), djw256, 2017 | 87 | 2017 |
| Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration SCY Leung, TO Nielsen, LA Zabaglo, I Arun, SS Badve, AL Bane, ... Histopathology 75 (2), 225-235, 2019 | 85 | 2019 |
| Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups C Parra-Herran, J Lerner-Ellis, B Xu, S Khalouei, D Bassiouny, M Cesari, ... Modern Pathology 30 (12), 1748-1759, 2017 | 79 | 2017 |
| Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence K Han, S Nofech-Mozes, S Narod, W Hanna, D Vesprini, R Saskin, ... Clinical oncology 24 (3), 183-189, 2012 | 77 | 2012 |
| Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast N Lalani, L Paszat, R Sutradhar, D Thiruchelvam, S Nofech-Mozes, ... International Journal of Radiation Oncology* Biology* Physics 90 (5), 1017-1024, 2014 | 72 | 2014 |
